1. “It’s Not the Destination, It’s the Journey”: 2011 Society of Surgical Oncology Presidential Address

   • Mitchell C. Posner

   Healthcare Policy and Outcomes 07 March 2012 Pages: 2073 - 2080

   

2. The Real Estate of Gastric Cancer Induction Therapy: Location Versus Intrinsic Molecular Architecture

   • Roderich E. Schwarz
   • John C. Mansour

   Gastrointestinal Oncology 26 April 2012 Pages: 2081 - 2083

3. Lymph Node Yield and Oncologic Outcome after Colorectal Cancer Resection

   • Garrett M. Nash

   Colorectal Cancer 29 March 2012 Pages: 2084 - 2085

4. Sestamibi-Negative Patients: To Operate or Image?

   • Carrie C. Lubitz
   • Herbert Chen

   Endocrine Tumors 24 April 2012 Pages: 2086 - 2087

5. Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer

   • E. C. Smyth
   • M. Capanu
   • M. A. Shah

   Healthcare Policy and Outcomes 07 March 2012 Pages: 2088 - 2094

6. Robotic versus Laparoscopic Proctectomy for Rectal Cancer: A Meta-analysis

   • Sameer Memon
   • Alexander G. Heriot
   • A. Craig Lynch

   Healthcare Policy and Outcomes 16 February 2012 Pages: 2095 - 2101

   

7. Medullary Thyroid Carcinoma: Ethical Issues for the Surgeon

   • Andrew G. Shuman
   • Ashok R. Shaha
   • Luc G. T. Morris

   Healthcare Policy and Outcomes 10 February 2012 Pages: 2102 - 2107

8. Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer

   • Daniel Reim
   • Ralf Gertler
   • Christoph Schumacher

   Gastrointestinal Oncology 01 December 2011 Pages: 2108 - 2118

   

9. Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients

   • Sylvie Lorenzen
   • Susanne Blank
   • Katja Ott

   Gastrointestinal Oncology 07 March 2012 Pages: 2119 - 2127

   

10. Surgery in Esophageal and Gastric Cancer Patients: What is the Role for Nutrition Support in your Daily Practice?

    • Christophe Mariette
    • Marie-Laure De Botton
    • Guillaume Piessen

    Gastrointestinal Oncology 10 February 2012 Pages: 2128 - 2134

    

11. Comparison Between Radical Esophagectomy and Definitive Chemoradiotherapy in Patients with Clinical T1bN0M0 Esophageal Cancer

    • Masaaki Motoori
    • Masahiko Yano
    • Osamu Ishikawa

    Gastrointestinal Oncology 01 February 2012 Pages: 2135 - 2141

    

12. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer

    • Koen Talsma
    • Pieter van Hagen
    • Bas P. L. Wijnhoven

    Thoracic Oncology Open access 07 March 2012 Pages: 2142 - 2148

    

13. Endoscopic Tumor Length Is an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma

    • Bing-Yen Wang
    • Chao-Yu Liu
    • Ching-Yuan Cheng

    Thoracic Oncology 10 March 2012 Pages: 2149 - 2158

    

14. Vascular Endothelial Growth Factor Receptor 2 Gene Polymorphisms as Predictors for Tumor Recurrence and Overall Survival in Non-Small-Cell Lung Cancer

    • Faik G. Uzunoglu
    • Caroline Kaufmann
    • Yogesh K. Vashist

    Thoracic Oncology 07 March 2012 Pages: 2159 - 2168

    

15. The Relationship of Lymph Node Evaluation and Colorectal Cancer Survival After Curative Resection: A Multi-Institutional Study

    • Yukihide Kanemitsu
    • Koji Komori
    • Kenichi Sugihara

    Colorectal Cancer 01 February 2012 Pages: 2169 - 2177

    

16. Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using ¹⁸FDG-PET/CT

    • Skandan Shanmugan
    • Rodrigo Arrangoiz
    • Elin R. Sigurdson

    Gastrointestinal Oncology 07 March 2012 Pages: 2178 - 2185

    

17. The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study

    • Daphne Hompes
    • André D’Hoore
    • Joseph Kerger

    Gastrointestinal Oncology 07 March 2012 Pages: 2186 - 2194

    

18. Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer

    • Nuh N. Rahbari
    • Ulrich Bork
    • Jürgen Weitz

    Colorectal Cancer 10 January 2012 Pages: 2195 - 2202

    

19. Prognostic Factors for Locoregional Recurrences in Colon Cancer

    • M. A. G. Elferink
    • O. Visser
    • S. Siesling

    Colorectal Cancer 05 January 2012 Pages: 2203 - 2211

    

20. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis

    • Eisar Al-Sukhni
    • Laurent Milot
    • Erin Kennedy

    Colorectal Cancer 20 January 2012 Pages: 2212 - 2223

    

21. Repeat Hepatectomy for Metastatic Colorectal Cancer Is Safe but Marginally Effective

    • Natalie B. Jones
    • Megan E. McNally
    • Carl R. Schmidt

    Colorectal Cancer 30 December 2011 Pages: 2224 - 2229

    

22. Liver Injury Due to Chemotherapy-induced Sinusoidal Obstruction Syndrome Is Associated with Sinusoidal Capillarization

    • Masato Narita
    • Elie Oussoultzoglou
    • Philippe Bachellier

    Hepatobiliary Tumors 09 March 2012 Pages: 2230 - 2237

    

23. Salvage Hepatectomy for Local Recurrent Hepatocellular Carcinoma After Ablation Therapy

    • Hiroyuki Sugo
    • Yoichi Ishizaki
    • Seiji Kawasaki

    Hepatobiliary Tumors 01 February 2012 Pages: 2238 - 2245

    

24. Risk Factors of Peritoneal Recurrence and Outcome of Resected Peritoneal Recurrence After Liver Resection in Hepatocellular Carcinoma: Review of 1222 Cases of Hepatectomy in a Tertiary Institution

    • Alfred Wei Chieh Kow
    • Choon Hyuck David Kwon
    • Jae-Won Joh

    Hepatobiliary Tumors Open access 09 March 2012 Pages: 2246 - 2255

    

25. Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial

    • Michele Reni
    • Gianpaolo Balzano
    • Eugenio Villa

    Pancreatic Tumors 12 January 2012 Pages: 2256 - 2263

    

26. Clinical Significance of Folate Receptor β–expressing Tumor-associated Macrophages in Pancreatic Cancer

    • Hiroshi Kurahara
    • Sonshin Takao
    • Shoji Natsugoe

    Pancreatic Tumors 16 February 2012 Pages: 2264 - 2271

    

27. Primary Hyperparathyroidism and Negative Tc99 Sestamibi Imaging: To Operate or Not?

    • Benzon M. Dy
    • Melanie L. Richards
    • Clive S. Grant

    Endocrine Tumors 22 March 2012 Pages: 2272 - 2278

    

28. Clinical Implication of Elastography as a Prognostic Factor of Papillary Thyroid Microcarcinoma

    • Hee Jung Moon
    • Eun-Kyung Kim
    • Jin Young Kwak

    Endocrine Tumors 13 January 2012 Pages: 2279 - 2287

    

29. Robotic Versus Laparoscopic Resection of Large Adrenal Tumors

    • Orhan Agcaoglu
    • Shamil Aliyev
    • Eren Berber

    Endocrine Tumors 07 March 2012 Pages: 2288 - 2294

    

30. Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis

    • George A. Poultsides
    • Lyen C. Huang
    • Jeffrey A. Norton

    Endocrine Tumors 07 March 2012 Pages: 2295 - 2303

    

31. Clinical and Ultrasonographic Findings Affecting Nondiagnostic Results upon the Second Fine Needle Aspiration for Thyroid Nodules

    • Yoon Seong Choi
    • Soon Won Hong
    • Eun-Kyung Kim

    Head and Neck Oncology 07 March 2012 Pages: 2304 - 2309

    

32. Robotic Transaxillary Thyroid Lobectomy of a Follicular Neoplasm

    • Saleh Massasati
    • Salem Noureldine
    • Emad Kandil

    Endocrine Tumors—Streaming Video 10 March 2012 Pages: 2310 - 2310

33. Management of the Neck in the Setting of Definitive Chemoradiation: Is There a Consensus? A GETTEC Study

    • Juliette Thariat
    • Marc Hamoir
    • Xavier Dufour

    Head and Neck Oncology 09 March 2012 Pages: 2311 - 2319

    

34. Risk Factors for Gastric-Tube Dependence Following Tongue Reconstruction

    • Shimpei Miyamoto
    • Minoru Sakuraba
    • Ryuichi Hayashi

    Head and Neck Oncology 07 March 2012 Pages: 2320 - 2326

    

35. Alternatives for Optimizing Outcomes in Oncoplastic Breast Surgery

    • Mona P. Tan

    Breast Oncology 07 March 2012 Pages: 2327 - 2333

    

36. Race and the Prognostic Influence of p53 in Women with Breast Cancer

    • Keith A. Dookeran
    • James J. Dignam
    • Sarah Gehlert

    Breast Oncology 21 March 2012 Pages: 2334 - 2344

    

37. Outcome of Patients with Ductal Carcinoma In Situ and Sentinel Node Biopsy

    • T. J. Meretoja
    • P. S. Heikkilä
    • M. H. K. Leidenius

    Breast Oncology 07 March 2012 Pages: 2345 - 2351

38. Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion in Women with Heavily Pretreated Recurrent Ovarian Cancer

    • Wim P. Ceelen
    • Yves Van Nieuwenhove
    • Piet Pattyn

    Gynecologic Oncology 29 December 2009 Pages: 2352 - 2359

    

39. Merkel Cell Carcinoma of Unknown Primary Origin

    • Jeremiah L. Deneve
    • Jane L. Messina
    • Jonathan S. Zager

    Melanomas 21 January 2012 Pages: 2360 - 2366

    

40. Integration of Global Spectral Karyotyping, CGH Arrays, and Expression Arrays Reveals Important Genes in the Pathogenesis of Glioblastoma Multiforme

    • Paola E. Leone
    • M. Belén González
    • Juan L. García

    Neuro-Oncology 07 March 2012 Pages: 2367 - 2379

    

41. Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift

    • Maxine Sun
    • Firas Abdollah
    • Pierre I. Karakiewicz

    Urologic Oncology 10 February 2012 Pages: 2380 - 2387

    

42. Adjuvant Surgery in Testicular Cancer Patients Undergoing Postchemotherapy Retroperitoneal Lymph Node Dissection

    • Hooman Djaladat
    • Craig Nichols
    • Siamak Daneshmand

    Urologic Oncology 07 March 2012 Pages: 2388 - 2393

    

43. MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene

    • Kenoki Ohuchida
    • Kazuhiro Mizumoto
    • Masao Tanaka

    Pancreatic Tumors 10 March 2012 Pages: 2394 - 2402

    

44. Putatively Functional PLCE1 Variants and Susceptibility to Esophageal Squamous Cell Carcinoma (ESCC): A Case–Control Study in Eastern Chinese Populations

    • Haichuan Hu
    • Jingmin Yang
    • Haiquan Chen

    Translational Research and Biomarkers 28 December 2011 Pages: 2403 - 2410

    

45. Combination of Haptoglobin and Osteopontin Could Predict Colorectal Cancer Hepatic Metastasis

    • Lichao Sun
    • Jian Pan
    • Yuliang Ran

    Translational Research and Biomarkers 05 January 2012 Pages: 2411 - 2419

    

46. Erratum to: Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132

    • Dian Wang
    • Qiang Zhang
    • Burton L. Eisenberg

    Erratum 07 March 2012 Pages: 2420 - 2420

    

47. Erratum to: A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers

    • John H. Stewart IV
    • Perry Shen
    • Edward A. Levine

    Erratum 07 March 2012 Pages: 2421 - 2421